Cargando…
High-Density Lipoprotein-Targeted Therapies for Heart Failure
The main and common constituents of high-density lipoproteins (HDLs) are apolipoprotein A-I, cholesterol, and phospholipids. Biochemical heterogeneity of HDL particles is based on the variable presence of one or more representatives of at least 180 proteins, 200 lipid species, and 20 micro RNAs. HDL...
Autores principales: | Mishra, Mudit, De Geest, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767106/ https://www.ncbi.nlm.nih.gov/pubmed/33339429 http://dx.doi.org/10.3390/biomedicines8120620 |
Ejemplares similares
-
Impact of High-Density Lipoproteins on Sepsis
por: De Geest, Bart, et al.
Publicado: (2022) -
Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies
por: De Geest, Bart, et al.
Publicado: (2021) -
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials
por: Ji, Luxi, et al.
Publicado: (2023) -
New Perspectives on Cholesterol and Lipoprotein Metabolism
por: De Geest, Bart, et al.
Publicado: (2023) -
Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Muthuramu, Ilayaraja, et al.
Publicado: (2022)